Search Page

1

Cite

Share

The interleukin-8 pathway in cancer.

Waugh DJ, Wilson C. Waugh DJ, et al. Clin Cancer Res. 2008 Nov 1;14(21):6735-41. doi: 10.1158/1078-0432.CCR-07-4843. Clin Cancer Res. 2008. PMID: 18980965 Free article. Review.

Cite

Share

2

Cite

Share

Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods.

Murphy RG, Roddy AC, Srivastava S, Baena E, Waugh DJ, M O'Sullivan J, McArt DG, Jain S, LaBonte MJ. Murphy RG, et al. Among authors: waugh dj. NAR Genom Bioinform. 2020 Sep;2(3):lqaa062. doi: 10.1093/nargab/lqaa062. Epub 2020 Aug 20. NAR Genom Bioinform. 2020. PMID: 32856020 Free PMC article.

Cite

Share

3

Cite

Share

ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA.

Gilmore AR, Alderdice M, Savage KI, O'Reilly PG, Roddy AC, Dunne PD, Lawler M, McDade SS, Waugh DJ, McArt DG. Gilmore AR, et al. Among authors: waugh dj. Cancer Res. 2019 Apr 15;79(8):2072-2075. doi: 10.1158/0008-5472.CAN-18-1976. Epub 2019 Feb 13. Cancer Res. 2019. PMID: 30760519 Free article.

Cite

Share

4

Cite

Share

Expanding the Armamentarium for Castrate-resistant Prostate Cancer.

Waugh DJJ. Waugh DJJ. Eur Urol. 2017 Mar;71(3):328-329. doi: 10.1016/j.eururo.2016.05.022. Epub 2016 May 24. Eur Urol. 2017. PMID: 27234999 No abstract available.

Cite

Share

5

Cite

Share

ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation.

Hanna C, Dunne VL, Walker SM, Butterworth KT, McCabe N, Waugh DJJ, Kennedy RD, Prise KM. Hanna C, et al. Among authors: waugh djj. Cancers (Basel). 2020 Dec 30;13(1):79. doi: 10.3390/cancers13010079. Cancers (Basel). 2020. PMID: 33396656 Free PMC article.

Cite

Share

6

Cite

Share

Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma.

Armstrong CWD, Coulter JA, Ong CW, Maxwell PJ, Walker S, Butterworth KT, Lyubomska O, Berlingeri S, Gallagher R, O'Sullivan JM, Jain S, Mills IG, Prise KM, Bristow RG, LaBonte MJ, Waugh DJJ. Armstrong CWD, et al. Among authors: waugh djj. NAR Cancer. 2020 Sep;2(3):zcaa012. doi: 10.1093/narcan/zcaa012. Epub 2020 Jul 3. NAR Cancer. 2020. PMID: 32743555 Free PMC article.

Cite

Share

7

Cite

Share

Protocols for Studies on Genetically Engineered Mouse Models in Prostate Cancer.

Armstrong CWD, Lyubomska O, LaBonte MJ, Waugh DJJ. Armstrong CWD, et al. Among authors: waugh djj. Methods Mol Biol. 2018;1786:195-206. doi: 10.1007/978-1-4939-7845-8_11. Methods Mol Biol. 2018. PMID: 29786794

Cite

Share

8

Cite

Share

Multi-faceted roles for CXC-chemokines in prostate cancer progression.

Waugh DJ, Wilson C, Seaton A, Maxwell PJ. Waugh DJ, et al. Front Biosci. 2008 May 1;13:4595-604. doi: 10.2741/3025. Front Biosci. 2008. PMID: 18508531 Review.

Cite

Share

9

Cite

Share

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.

Walker SM, Knight LA, McCavigan AM, Logan GE, Berge V, Sherif A, Pandha H, Warren AY, Davidson C, Uprichard A, Blayney JK, Price B, Jellema GL, Steele CJ, Svindland A, McDade SS, Eden CG, Foster C, Mills IG, Neal DE, Mason MD, Kay EW, Waugh DJ, Harkin DP, Watson RW, Clarke NW, Kennedy RD. Walker SM, et al. Among authors: waugh dj. Eur Urol. 2017 Oct;72(4):509-518. doi: 10.1016/j.eururo.2017.03.027. Epub 2017 Apr 10. Eur Urol. 2017. PMID: 28408174 Free article.

Cite

Share

10

Cite

Share

Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists.

McCann C, Crawford N, Majkut J, Holohan C, Armstrong CWD, Maxwell PJ, Ong CW, LaBonte MJ, McDade SS, Waugh DJ, Longley DB. McCann C, et al. Among authors: waugh dj. Cell Death Dis. 2018 Oct 22;9(11):1081. doi: 10.1038/s41419-018-1125-5. Cell Death Dis. 2018. PMID: 30349042 Free PMC article.

Cite

Share